Application of vitamin D3 in the treatment of dry eye syndrome after FS-lasik

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900026563

Enrollment

Unknown

Registered

2019-10-14

Start date

2018-01-01

Completion date

Unknown

Last updated

2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye symdrome

Interventions

experimental group:Oral vitamin D3

control group:none

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Myopic patients, aged 18 to 50 with no dry eye history and volunteered to take the refractive surgery; 2. Stable refractive error for at least 2 years (within +/-0.5D).

Exclusion criteria

Exclusion criteria: 1) Inflammatory diseases of eyelid and its appendages and conjunctiva that have adverse effects on tear film; 2) lacrimal gland diseases or surgery; 3) abnormal eyelid structure or function; 4) eye diseases such as cataract, glaucoma, keratoconus, uveitis, retinal detachment, optic neuritis, etc.; 5) systemic diseases such as diabetes, hypertension, etc.; 6) Use of drugs that affect corneal metabolism; 7) long-term history of wearing contact lenses.

Design outcomes

Primary

Measure	Time frame
tear breakup time;Schimer test;corneal fluorescein staining;	—

Countries

China

Contacts

Public ContactLin Ying

Liuzhou Worker's Hospital

linying0320@sina.com+86 13507726874

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026